[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (60)

Search Parameters:
Keywords = VCT

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
19 pages, 3926 KiB  
Article
Analysis of High-Dose Ascorbate-Induced Cytotoxicity in Human Glioblastoma Cells and the Role of Dehydroascorbic Acid and Iron
by Alban Piotrowsky, Markus Burkard, Katharina Hammerschmidt, Hannah K. Ruple, Pia Nonnenmacher, Monika Schumacher, Christian Leischner, Susanne Berchtold, Luigi Marongiu, Thomas A. Kufer, Ulrich M. Lauer, Olga Renner and Sascha Venturelli
Antioxidants 2024, 13(9), 1095; https://doi.org/10.3390/antiox13091095 - 10 Sep 2024
Viewed by 658
Abstract
Several studies have demonstrated, both in vitro and in animal models, the anti-tumor efficacy of high-dose ascorbate treatment against a variety of tumor entities, including glioblastoma, the most common and aggressive primary malignant brain tumor. The aim of this study was to investigate [...] Read more.
Several studies have demonstrated, both in vitro and in animal models, the anti-tumor efficacy of high-dose ascorbate treatment against a variety of tumor entities, including glioblastoma, the most common and aggressive primary malignant brain tumor. The aim of this study was to investigate the effects of high-dose ascorbate as well as dehydroascorbic acid on human glioblastoma cell lines and to evaluate different treatment conditions for the combined administration of ascorbate with magnesium (Mg2+) and iron (Fe3+). Intracellular levels of reactive oxygen species and the induction of cell death following ascorbate treatment were also investigated. We demonstrated high cytotoxicity and antiproliferative efficacy of high-dose ascorbate in human glioblastoma cells, whereas much weaker effects were observed for dehydroascorbic acid. Ascorbate-induced cell death was independent of apoptosis. Both the reduction in cell viability and the ascorbate-induced generation of intracellular reactive oxygen species could be significantly increased by incubating the cells with Fe3+ before ascorbate treatment. This work demonstrates, for the first time, an increase in ascorbate-induced intracellular ROS formation and cytotoxicity in human glioblastoma cells by pre-treatment of the tumor cells with ferric iron, as well as caspase-3 independence of cell death induced by high-dose ascorbate. Instead, the cell death mechanism caused by high-dose ascorbate in glioblastoma cells shows evidence of ferroptosis. The results of the present work provide insights into the efficacy and mode of action of pharmacological ascorbate for the therapy of glioblastoma, as well as indications for possible approaches to increase the effectiveness of ascorbate treatment. Full article
Show Figures

Figure 1

Figure 1
<p>Evaluation of the sensitivity of human glioblastoma cells to high-dose ascorbate and DHA treatment. SF268 cells were treated for 24 h or 48 h with different concentrations of Asc or DHA (0.2 mM, 1 mM, 2 mM, and 4 mM). Triton X-100 at 0.1% (<span class="html-italic">v</span>/<span class="html-italic">v</span>) served as a positive control. Cell viability was assessed by MUH assay (<b>a</b>) and SRB assay (<b>b</b>). Results are presented as percentage of fluorescence intensity and viability, respectively, compared to the untreated control. (<b>c</b>) Antiproliferative effects were detected by cell number determination using the Lionheart FX automated microscope (BioTek Instruments, Inc., Winooski, VT, USA). Treatment was performed 24 h after seeding. Results are presented as cell number per well every 4 h. Three independent experiments were performed, each in duplicates. Error bars represent mean ± SD, statistical analysis with one-way ANOVA and subsequent Dunnett’s multiple comparisons test, confidence interval 95%. *: <span class="html-italic">p</span> ≤ 0.05; ***: <span class="html-italic">p</span> ≤ 0.001. Asc, ascorbate; DHA, dehydroascorbic acid; MUH, 4-methylumbelliferyl heptanoate; SRB, sulforhodamine B.</p>
Full article ">Figure 2
<p>Effect of iron and magnesium on ascorbate-induced cytotoxicity in human glioblastoma cells shown by MUH assay. SF268 cells were treated with different concentrations of Asc for 24 h (0.2 mM, 0.4 mM, 0.6 mM, 0.8 mM, and 1 mM). Triton X-100 at 0.1% (<span class="html-italic">v</span>/<span class="html-italic">v</span>) served as a positive control. Cells were either treated with Asc alone (<b>a</b>), pre-incubated with FeCl<sub>3</sub> (100 µM) or MgCl<sub>2</sub> (5 mM) for 24 h immediately prior to Asc treatment (<b>b</b>), or co-incubated with Asc and FeCl<sub>3</sub> or MgCl<sub>2</sub> (<b>c</b>). Results are presented as percentage of fluorescence intensity compared to the untreated control. Three independent experiments were performed, each in duplicates. Error bars represent mean ± SD, statistical analysis with one-way ANOVA and subsequent Dunnett’s multiple comparisons test, confidence interval 95%. *: <span class="html-italic">p</span> ≤ 0.05; ***: <span class="html-italic">p</span> ≤ 0.001. Asc, ascorbate; co, co-incubation; Fe, ferric chloride (FeCl<sub>3</sub>); Mg, magnesium chloride (MgCl<sub>2</sub>); MUH, 4-methylumbelliferyl heptanoate; pre, pre-incubation.</p>
Full article ">Figure 3
<p>Effect of iron on ascorbate-induced ROS formation in human glioblastoma cells determined by DCFH-DA assay. SF268 cells were treated with different concentrations of Asc (0.2 mM, 0.4 mM, 0.6 mM, 0.8 mM, 1 mM, and 2 mM) for different time periods (3 h, 4 h, 5 h, and 6 h); 1 mM TBH served as a positive control. After Asc treatment, cells were stained with DCFH-DA and analyzed by flow cytometry (<b>a</b>). The DCF-A histograms were used to determine the percentages of DCF-positive cells, indicating cells with increased intracellular ROS levels (<b>b</b>). Cells were either treated with Asc alone (red dots) or pre-incubated with FeCl<sub>3</sub> (100 µM) for 24 h immediately prior to Asc treatment (green squares). Three independent experiments were performed. Error bars represent mean ± SD, statistical analysis with one-way ANOVA and subsequent Dunnett’s multiple comparisons test, confidence interval 95%. *: <span class="html-italic">p</span> ≤ 0.05; **: <span class="html-italic">p</span> ≤ 0.01; ***: <span class="html-italic">p</span> ≤ 0.001. Asc, ascorbate; DCF, dichlorofluorescein; DCFH-DA, dichlorodihydrofluorescein diacetate; Fe, ferric chloride (FeCl<sub>3</sub>); pre, pre-incubation; ROS, reactive oxygen species; TBH, tert-butyl hydroperoxide.</p>
Full article ">Figure 4
<p>Cell cycle analysis and evaluation of apoptosis by high-dose ascorbate in human glioblastoma cells. SF268 cells were treated with different concentrations of Asc for 24 h (0.2 mM, 0.4 mM, 0.6 mM, 0.8 mM, and 1 mM) and cell cycle analysis was performed after PI staining by flow cytometry. The PI-H histogram was used to determine the percentage of cells in each cell cycle phase as well as apoptotic cells, as exemplified for untreated cells and the positive control (5 µM STS) (<b>a</b>). No increase in SubG1 fraction was detected following treatment with high-dose Asc (<b>b</b>). Western blot analysis of caspase-3 cleavage in cell lysates of SF268 cells treated with the indicated Asc concentrations or STS as positive control for 6 h (<b>c</b>). Equal protein loading was confirmed by GAPDH detection. After treatment for 6 h with 1 mM Asc, nuclei were stained with Hoechst 33342, live cells with Live Green, and dead cells with Dead Red. Cells were photographed with the Lionheart FX automated microscope (BioTek Instruments, Inc.) (<b>d</b>). The white bar is equivalent to 100 µm. 10 µM STS served as a positive control. Three independent experiments were performed. Error bars represent the mean ± SD. Asc, ascorbate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PI, propidium iodide; STS, staurosporine.</p>
Full article ">Figure 5
<p>Investigation of ferroptosis by high-dose ascorbate in human glioblastoma cells. SF268 cells were treated with different concentrations of Asc for 24 h (0.2 mM, 0.4 mM, 0.6 mM, 0.8 mM, and 1 mM) with or without 50 µM DFO and cell viability was determined by MUH assay (<b>a</b>) and SRB assay (<b>b</b>). Western blot analysis of TfR1 and GPX4 expression in cell lysates of SF268 cells treated with the indicated Asc concentrations or RSL3 as a positive control for 8 h (<b>c</b>). Equal protein loading was confirmed by GAPDH detection. Protein expression was quantified by densitometry (ImageJ version 1.54, National Institutes of Health, Bethesda, MD, USA), normalized to GAPDH and shown relative to the untreated control (<b>d</b>). Error bars represent mean ± SD, statistical analysis with one-way ANOVA and subsequent Dunnett’s multiple comparisons test, confidence interval 95%. Asterisks indicate significant differences between ascorbate with and without DFO. **: <span class="html-italic">p</span> ≤ 0.01; ***: <span class="html-italic">p</span> ≤ 0.001. Asc, ascorbate; DFO, deferoxamine mesylate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GPX4, glutathione peroxidase 4; RSL3, RAS-selective lethal 3; TfR1, transferrin receptor 1.</p>
Full article ">
15 pages, 8557 KiB  
Article
Personalized Visualization of the Gestures of Parkinson’s Disease Patients with Virtual Reality
by Konstantinos Sakkas, Eirini Georgia Dimitriou, Niki Eleni Ntagka, Nikolaos Giannakeas, Konstantinos Kalafatakis, Alexandros T. Tzallas and Evripidis Glavas
Future Internet 2024, 16(9), 305; https://doi.org/10.3390/fi16090305 - 23 Aug 2024
Viewed by 689
Abstract
Parkinson’s disease is a neurological disorder characterized by motor and non-motor symptoms. Assessment methods, despite the many years of existence of the disease, lack individualized visualization. On the other hand, virtual reality promises immersion and realism. In this paper, we develop an integrated [...] Read more.
Parkinson’s disease is a neurological disorder characterized by motor and non-motor symptoms. Assessment methods, despite the many years of existence of the disease, lack individualized visualization. On the other hand, virtual reality promises immersion and realism. In this paper, we develop an integrated system for visualizing the gestures of Parkinson’s disease patients in a virtual reality environment. With this application, clinicians will have information about the unique motor patterns and challenges they must address in each individual patient’s case, while the collected data can travel and be easily and instantly visualized in any location. At the beginning of this research, the current terms of immersive technologies in conjunction with data visualization and Parkinson’s disease are described. Through an extensive systematic literature review, the technological developments in the field of Parkinson’s data visualization are presented. The findings of the review lead to the experimental procedure and implementation of the application. The conclusions drawn from this work fuel future extensions on the contribution of immersive technologies to various diseases. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The structure of SmartGlove.</p>
Full article ">Figure 2
<p>The SmartGlove design architecture.</p>
Full article ">Figure 3
<p>Exporting graphics from SmartGlove data.</p>
Full article ">Figure 4
<p>User information room.</p>
Full article ">Figure 5
<p>Data selection by the user.</p>
Full article ">Figure 6
<p>Application analysis.</p>
Full article ">Figure 7
<p>Visualization room.</p>
Full article ">Figure 8
<p>Printing the leap base.</p>
Full article ">Figure 9
<p>Placement of Leap in Meta Quest 2 (Meta Platforms, Inc., Cambridge, MA, USA).</p>
Full article ">Figure 10
<p>Hand view via Leap.</p>
Full article ">Figure 11
<p>User interaction.</p>
Full article ">Figure 12
<p>Part of experimental procedure.</p>
Full article ">Figure 13
<p>Evaluation of the experiment by the participants.</p>
Full article ">Figure 14
<p>Implementation evaluation by neurological physicians.</p>
Full article ">
19 pages, 3463 KiB  
Article
A Mathematical Model of Pressure Ulcer Formation to Facilitate Prevention and Management
by Ioannis G. Violaris, Konstantinos Kalafatakis, Nikolaos Giannakeas, Alexandros T. Tzallas and Markos Tsipouras
Methods Protoc. 2024, 7(4), 62; https://doi.org/10.3390/mps7040062 - 13 Aug 2024
Viewed by 799
Abstract
Pressure ulcers are a frequent issue involving localized damage to the skin and underlying tissues, commonly arising from prolonged hospitalization and immobilization. This paper introduces a mathematical model designed to elucidate the mechanics behind pressure ulcer formation, aiming to predict its occurrence and [...] Read more.
Pressure ulcers are a frequent issue involving localized damage to the skin and underlying tissues, commonly arising from prolonged hospitalization and immobilization. This paper introduces a mathematical model designed to elucidate the mechanics behind pressure ulcer formation, aiming to predict its occurrence and assist in its prevention. Utilizing differential geometry and elasticity theory, the model represents human skin and simulates its deformation under pressure. Additionally, a system of ordinary differential equations is employed to predict the outcomes of these deformations, estimating the cellular death rate in skin tissues and underlying layers. The model also incorporates changes in blood flow resulting from alterations in skin geometry. This comprehensive approach provides new insights into the optimal bed surfaces required to prevent pressure ulcers and offers a general predictive method to aid healthcare personnel in making informed decisions for at-risk patients. Compared to existing models in the literature, our model delivers a more thorough prediction method that aligns well with current data. It can forecast the time required for an immobilized individual to develop an ulcer in various body parts, considering different initial health conditions and treatment strategies. Full article
(This article belongs to the Section Biomedical Sciences and Physiology)
Show Figures

Figure 1

Figure 1
<p>The surface under question along with the stress acting in all three directions.</p>
Full article ">Figure 2
<p>The form that human skin takes under pressure. Here we present an example of a particular solution. Assuming that something like, for example, a human finger pushes the skin and creates an indentation, we show how our model predicts it would look like.</p>
Full article ">Figure 3
<p>An example of geodesic triangles and how their vertices would curve under a change in the curvature of the surface they are inscribed upon.</p>
Full article ">Figure 4
<p>Explanations for the variables used in the ODE model are given as well as the values used.</p>
Full article ">Figure 5
<p>Examples of the surface of a human back based on measurements from the literature [<a href="#B7-mps-07-00062" class="html-bibr">7</a>]. The axes are all in meters.</p>
Full article ">Figure 6
<p>A figure of the human body along with areas where pressure ulcers usually appear and their close mathematical equivalents.</p>
Full article ">Figure 7
<p>In this chart, the process through which the model is used is explained.</p>
Full article ">Figure 8
<p>The shape of the assumed human back that we used in the modeling process.</p>
Full article ">Figure 9
<p>The shape that the back has taken after pressure is acting on it. Here, the difference is hard to see. This will become evident in the next figure when the two are put together for comparison.</p>
Full article ">Figure 10
<p>The two previous figures appearing together, one overlapping the other. It is evident that the area increased. This would not be so easy to see in real life due to the fact that the object in question is 3−dimensional and not 2−dimensional as it appears here.</p>
Full article ">Figure 11
<p>The plots of the Gaussian curvature of the surface of the human back at each point appear here.</p>
Full article ">Figure 12
<p>The prediction of the ODE model regarding cellular death as a function of time. This is the body of a perfectly healthy individual after immobilization without changing his position.</p>
Full article ">Figure 13
<p>The prediction of our model on an individual whose initial partial oxygen pressure was reduced by <math display="inline"><semantics> <mrow> <mn>15</mn> <mo>%</mo> </mrow> </semantics></math> from the start due to other underlying health problems.</p>
Full article ">Figure 14
<p>Model prediction of a healthy individual whose position is changed every 2 h. We used a step function to imitate the effect, changing the pressure to 1 every 2 h and then back to the predicted value when 2 h have elapsed.</p>
Full article ">Figure 15
<p>Model prediction of an unhealthy individual when pressure is alleviated every 2 h.</p>
Full article ">
12 pages, 1418 KiB  
Article
The Measurement of Contrast Sensitivity in Near Vision: The Use of a Digital System vs. a Conventional Printed Test
by Kevin J. Mena-Guevara, David P. Piñero, María José Luque and Dolores de Fez
Technologies 2024, 12(7), 108; https://doi.org/10.3390/technologies12070108 - 9 Jul 2024
Viewed by 1500
Abstract
In recent years, there has been intense development of digital diagnostic tests for vision. All of these tests must be validated for clinical use. The current study enrolled 51 healthy individuals (age 19–72 years) in which achromatic contrast sensitivity function (CSF) in near [...] Read more.
In recent years, there has been intense development of digital diagnostic tests for vision. All of these tests must be validated for clinical use. The current study enrolled 51 healthy individuals (age 19–72 years) in which achromatic contrast sensitivity function (CSF) in near vision was measured with the printed Vistech VCTS test (Stereo Optical Co., Inc., Chicago, IL, USA) and the Optopad-CSF (developed by our research group to be used on an iPad). Likewise, chromatic CSF was evaluated with a digital test. Statistically significant differences between tests were only found for the two higher spatial frequencies evaluated (p = 0.012 and <0.001, respectively). The mean achromatic index of contrast sensitivity (ICS) was 0.02 ± 1.07 and −0.76 ± 1.63 for the Vistech VCTS and Optopad tests, respectively (p < 0.001). The ranges of agreement between tests were 0.55, 0.76, 0.78, and 0.69 log units for the spatial frequencies of 1.5, 3, 6, and 12 cpd, respectively. The mean chromatic ICS values were −20.56 ± 0.96 and −0.16 ± 0.99 for the CSF-T and CSF-D plates, respectively (p < 0.001). Furthermore, better achromatic, red–green, and blue–yellow CSF values were found in the youngest groups. The digital test allows the fast measurement of near-achromatic and chromatic CSF using a colorimetrically calibrated iPad, but the achromatic measures cannot be used interchangeably with those obtained with a conventional printed test. Full article
Show Figures

Figure 1

Figure 1
<p>Bland–Altman analysis for near achromatic contrast sensitivity: Vistech VCTS vs. Optopad-CSF (digital test). From left to right, top to bottom: F = 1.5 cpd, F = 3 cpd, F = 6 cpd, and F = 12 cpd, respectively.</p>
Full article ">Figure 2
<p>Near achromatic contrast sensitivity functions (CSFs) by age ranges measured with both instruments: Vistech VCTS (<b>right</b>) and Optopad-CSF (<b>left</b>).</p>
Full article ">Figure 3
<p>Chromatic contrast sensitivity by age ranges measured with the Optopad-CSF test for the red–green (CSF-T) and blue–yellow (CSF-D) mechanisms.</p>
Full article ">
18 pages, 3068 KiB  
Article
Multimodal Therapy Approaches for NUT Carcinoma by Dual Combination of Oncolytic Virus Talimogene Laherparepvec with Small Molecule Inhibitors
by Stavros Sotiriadis, Julia Beil, Susanne Berchtold, Irina Smirnow, Andrea Schenk and Ulrich M. Lauer
Viruses 2024, 16(5), 775; https://doi.org/10.3390/v16050775 - 14 May 2024
Viewed by 1293
Abstract
NUT (nuclear-protein-in-testis) carcinoma (NC) is a highly aggressive tumor disease. Given that current treatment regimens offer a median survival of six months only, it is likely that this type of tumor requires an extended multimodal treatment approach to improve prognosis. In an earlier [...] Read more.
NUT (nuclear-protein-in-testis) carcinoma (NC) is a highly aggressive tumor disease. Given that current treatment regimens offer a median survival of six months only, it is likely that this type of tumor requires an extended multimodal treatment approach to improve prognosis. In an earlier case report, we could show that an oncolytic herpes simplex virus (T-VEC) is functional in NC patients. To identify further combination partners for T-VEC, we have investigated the anti-tumoral effects of T-VEC and five different small molecule inhibitors (SMIs) alone and in combination in human NC cell lines. Dual combinations were found to result in higher rates of tumor cell reductions when compared to the respective monotherapy as demonstrated by viability assays and real-time tumor cell growth monitoring. Interestingly, we found that the combination of T-VEC with SMIs resulted in both stronger and earlier reductions in the expression of c-Myc, a main driver of NC cell proliferation, when compared to T-VEC monotherapy. These results indicate the great potential of combinatorial therapies using oncolytic viruses and SMIs to control the highly aggressive behavior of NC cancers and probably will pave the way for innovative multimodal clinical studies in the near future. Full article
(This article belongs to the Special Issue Oncolytic Viruses as Immunotherapeutic Agents)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Viability of human NC cell line HCC2429 after dual combination treatment with T-VEC and small molecule inhibitors (SMIs): HCC2429 cells were infected with T-VEC at a multiplicity of infection (MOI) of 0.001 and treated with the SMIs vorinostat (500 nM) (<b>A</b>), panobinostat (2.5 nM) (<b>B</b>), fimepinostat (0.5 nM) (<b>C</b>), GNE-781 (25 nM) (<b>D</b>), and palbociclib (100 nM) (<b>E</b>) in dual combination regimes or alone, or remained untreated (MOCK). The remaining NC tumor cells were determined at 72 h post-infection (hpi) by SRB viability assays. The mean ± SD of at least two independent experiments performed in quadruplicates is shown. Reported significances refer to dual combination compared to the respective monotherapy with the lowest remaining cell viability. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 2
<p>Viability of human NC cell line 143100 after dual combination treatment with T-VEC and small molecule inhibitors (SMIs): 143100 cells were infected with T-VEC at a multiplicity of infection (MOI) of 0.00005 and treated with the SMIs vorinostat (1 µM) (<b>A</b>), panobinostat (2.5 nM) (<b>B</b>), fimepinostat (1 nM) (<b>C</b>), GNE-781 (25 nM) (<b>D</b>), and palbociclib (100 nM) (<b>E</b>) in dual combination or alone, or remained untreated (MOCK). The remaining NC tumor cells were determined at 72 h post-infection (hpi) by SRB viability assays. The mean ± SD of at least two independent experiments performed in triplicates is shown. Reported significances refer to dual combination compared to the respective monotherapy with the lowest remaining cell viability. ** <span class="html-italic">p</span> &lt; 0.01, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 3
<p>Viability of human NC cell line 10-15 after dual combination treatment with T-VEC and small molecule inhibitors (SMIs): 10-15 cells were infected with T-VEC at a multiplicity of infection (MOI) of 0.0005 and treated with the SMIs vorinostat (500 nM) (<b>A</b>), panobinostat (2.5 nM) (<b>B</b>), fimepinostat (0.5 nM) (<b>C</b>), GNE-781 (10 nM) (<b>D</b>), and palbociclib (25 nM) (<b>E</b>) in dual combination regimes or alone, or remained untreated (MOCK). The remaining NC tumor cells were determined at 72 h post-infection (hpi) by SRB viability assays. The mean ± SD of at least two independent experiments performed in quadruplicates is shown. Reported significances refer to dual combination compared to the respective monotherapy with the lowest remaining cell viability. ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 4
<p>Real-time analysis of HCC2429 NC tumor cells under treatment with T-VEC alone or under dual combination therapies with small molecule inhibitors (SMIs). HCC2429 tumor cells were treated at 24 h after seeding with T-VEC (MOI 0.001) or with the SMI at the indicated concentration alone (vorinostat (500 nM) (<b>A</b>), panobinostat (2.5 nM) (<b>B</b>), fimepinostat (0.5 nM) (<b>C</b>), GNE-781 (25 nM) (<b>D</b>), and palbociclib (100 nM) (<b>E</b>)) or in combination. Triton X-100 0.1% was added as a negative control, resulting in maximal tumor cell lysis. Real-time cell proliferation was monitored using the xCELLigence<sup>®</sup> RTCA SP system 1.2.1. Cell index on the y-axis is defined by measured electrode impedance. Vertical dashed lines mark the point of infection. MOCK, Triton X-100 and T-VEC curves are the same in each graph. Mean ± SD of one representative experiment at least performed in quadruplicates is shown.</p>
Full article ">Figure 5
<p>Modulation of c-Myc (Myc) protein expression after treatment of HCC2429 cells for 24 (<b>A</b>), 48 (<b>B</b>) and 72 (<b>C</b>) hours (h) with T-VEC and small molecule inhibitors (SMIs) alone or in dual combination. HCC2429 cells were treated with T-VEC (MOI 0.001), vorinostat (500 nM), panobinostat (2.5 nM), fimepinostat (0.5 nM) alone or T-VEC in dual combination with a distinct SMI or remained untreated (MOCK). Anti-ß-Actin and anti-Vinculin antibodies were used to provide loading controls. Quantification of Myc band intensities as a function of the control bands (ß-Actin, Vinculin) is shown in the graphs on the right at 24 hpi (<b>A</b>), 48 hpi (<b>B</b>) and 72 hpi (<b>C</b>), calculated relative to MOCK.</p>
Full article ">Figure 6
<p>Replication of T-VEC in NC cell lines HCC2429 (<b>A</b>), 143100 (<b>B</b>), 10-15 (<b>C</b>), 690100 (<b>D</b>), 14169 (<b>E</b>) alone and after combination with small molecule inhibitors (SMIs): vorinostat, panobinostat, fimepinostat, GNE-781, or palbociclib was given at cell line-adjusted concentrations to NC tumor cells infected with T-VEC at cell line-adjusted multiplicity of infection (MOI). Viral replication was analyzed via plaque assay at 1, 24, 48 and 72 h post-infection (hpi). At least two independent experiments performed in duplicates are represented. PFU; plaque forming unit.</p>
Full article ">
11 pages, 312 KiB  
Article
HIV Voluntary Counselling and Testing Utilisation among School of Healthcare Sciences Undergraduate Students at the University of Limpopo
by Melitah Molatelo Rasweswe, Mamare Adelaide Bopape and Tshepo Albert Ntho
Int. J. Environ. Res. Public Health 2024, 21(2), 183; https://doi.org/10.3390/ijerph21020183 - 6 Feb 2024
Cited by 1 | Viewed by 1764
Abstract
Existing evidence indicates that South African university students have low utilisation of Human Immunodeficiency Virus (HIV) Voluntary Counselling and Testing (VCT). A cross-sectional survey was conducted to determine the utilisation of HIV VCT among undergraduate students in the School of Healthcare Sciences. Structured [...] Read more.
Existing evidence indicates that South African university students have low utilisation of Human Immunodeficiency Virus (HIV) Voluntary Counselling and Testing (VCT). A cross-sectional survey was conducted to determine the utilisation of HIV VCT among undergraduate students in the School of Healthcare Sciences. Structured questionnaires were used to collect data through Google Forms. The results are presented through descriptions and percentages and illustrated in tables. Out of 389 undergraduate students, only 324 completed the questionnaire. The majority (97.2%) were aware of the health centre on campus, while only (74.7%) knew about the HIV VCT services offered on campus. Despite the awareness, many (36.7%) do not utilise the campus HIV VCT services, and some (9.6%) have never tested for HIV. There was an association between awareness of Voluntary Counselling and Testing of HIV services offered at the campus health and wellness centre and utilisation of HIV Voluntary Counselling and Testing at (<0.001). Therefore, it is imperative to urgently escalate the level of HIV/AIDS education in higher institutions of learning and emphasise the mounting danger of HIV infection and the immense importance of regular HIV testing. The findings of this study could serve as a foundation for creating HIV prevention and control programmes for youth, particularly in higher education institutions. Full article
20 pages, 3278 KiB  
Article
In Vitro Sensitivity of Neuroendocrine Neoplasms to an Armed Oncolytic Measles Vaccine Virus
by Nikolai V. Scheicher, Susanne Berchtold, Julia Beil, Irina Smirnow, Andrea Schenk and Ulrich M. Lauer
Cancers 2024, 16(3), 488; https://doi.org/10.3390/cancers16030488 - 23 Jan 2024
Viewed by 1560
Abstract
Neuroendocrine neoplasms represent a heterogenous group of rare tumors whose current therapeutic options show only limited efficacy. Oncolytic viruses exert their mode of action through (onco-)lysis of infected tumor cells and the induction of a systemic antitumoral immune response in a virus-induced inflammatory [...] Read more.
Neuroendocrine neoplasms represent a heterogenous group of rare tumors whose current therapeutic options show only limited efficacy. Oncolytic viruses exert their mode of action through (onco-)lysis of infected tumor cells and the induction of a systemic antitumoral immune response in a virus-induced inflammatory micromilieu. Here, we investigated the potential of our well-established second-generation suicide-gene armed oncolytic measles vaccine virus (MeV-SCD) in five human NEN cell lines. First, (i) expression of the MeV receptor CD46 and (ii) its correlation with primary infection rates were analyzed. Next, (iii) promising combination partners for MeV-SCD were tested by employing either the prodrug 5-fluorocytosine, which is converted into the chemotherapeutic compound 5-fluorouracil, or the mTOR-inhibitor everolimus. As a result, MeV-SCD was found to kill all NEN tumor cell lines efficiently in a dose-dependent manner. This oncolytic effect was further enhanced by exploiting the prodrug-converting system, which was found to be highly instrumental in overcoming the partial resistance found in a single NEN cell line. Furthermore, viral replication was unaffected by everolimus, which is a basic requirement for combined use in NEN patients. These data suggest that MeV-SCD has profound potential for patients with NEN, thus paving the way for early clinical trials. Full article
(This article belongs to the Special Issue Oncolytic Viruses as an Emerging Aspect of Immune Oncology)
Show Figures

Figure 1

Figure 1
<p>Schematic overview of the recombinant measles vaccine viral constructs MeV-SCD and MeV-GFP. Besides the viral genes <span class="html-italic">N</span> (encoding nucleoprotein), <span class="html-italic">P</span> (encoding phosphoprotein), <span class="html-italic">M</span> (encoding matrix protein), <span class="html-italic">F</span> (encoding fusion protein), <span class="html-italic">H</span> (encoding hemagglutinin protein) and <span class="html-italic">L</span> (encoding large protein), the recombinant MeV cDNA contains an additional transcription unit encoding SCD or GFP downstream of the leader (ld) position.</p>
Full article ">Figure 2
<p>Determination of CD46 receptor expression on human NET/NEC tumor cell lines. The NET/NEC tumor cell lines BON1, HROC57, H727, UMC-11 and QGP-1 were stained with CD46 antibody (red histograms) or an isotype control (black histograms). Mean fluorescence was measured by flow cytometry. Mean fluorescence index (MFI) is the arithmetic mean of the CD46 receptor signal divided by the arithmetic mean of the isotype control signal. MFI 20 is considered as the minimum threshold required for syncytia formation.</p>
Full article ">Figure 3
<p>Primary infection rates of human NET/NEC tumor cell lines after infection with MeV-GFP. The NET/NEC tumor cell lines BON1, HROC57, H727, UMC-11 and QGP-1 were infected with the green fluorescent protein (GFP)-expressing measles vaccine virus MeV-GFP at different MOIs (0.1, 1, 10). At 24 hpi, the percentage of GFP-expressing cells was determined by flow cytometry. Mean and standard deviation of three independent experiments are shown. MOCK: untreated control. MOI: multiplicity of infection.</p>
Full article ">Figure 4
<p>Viability of human NET/NEC tumor cell lines after infection with MeV-SCD. The NET/NEC tumor cell lines BON1, HROC57, H727, UMC-11, and QGP-1 were infected with the suicide gene-armed measles vaccine virus MeV-SCD at indicated MOIs. At 96 hpi, the remaining tumor cell masses were determined by SRB viability assay. Displayed are mean and standard deviation of one representative experiment performed in quadruplicates. MOCK: untreated control. MOI: multiplicity of infection. * <span class="html-italic">p</span> &lt; 0.05, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 5
<p>Immunoblot analysis of MeV-encoded SCD protein expression in human NET/NEC tumor cell lines. The NET/NEC tumor cell lines HROC57, UMC-11, QGP-1, BON1, and H727 were infected with the suicide gene-armed measles vaccine virus MeV-SCD at MOIs adjusted to the respective cell line-dependent sensitivity to virus infection. Whole-cellular protein extraction and immunoblot analysis with an anti-SCD antibody were performed at 96 hpi. Vinculin was used as a loading control.</p>
Full article ">Figure 6
<p>Susceptibility of human NET/NEC tumor cell lines to the chemotherapeutic compound 5-fluorouracil (5-FU). The NET/NEC tumor cell lines BON1, HROC57, H727, UMC-11, and QGP-1 were treated with rising concentrations of 5-FU, and the remaining tumor cell masses were measured at 96 h post-treatment (hpt) by SRB viability assay. Displayed are mean and standard deviation of two independent experiments performed in triplicates. MOCK: untreated control. * <span class="html-italic">p</span> &lt; 0.05, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 7
<p>Remaining NET/NEC tumor cell masses after treatment with MeV-SCD and the prodrug 5-FC. The NET/NEC tumor cell lines BON1, HROC57, H727, UMC-11, and QGP-1 were infected with the suicide gene-armed measles vaccine virus MeV-SCD at MOIs adjusted to the respective cell line-dependent sensitivity to virus infection. At 3 hpi, 1 mM 5-FC was added, and cell viability was analyzed via SRB assay at 96 hpi. Displayed are mean and standard deviation of two independent experiments performed in quadruplicate. MOCK; untreated control. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 8
<p>Replication of MeV-SCD in five human NET/NEC cell lines with and without addition of 5-FC. The NET/NEC tumor cell lines BON1, HROC57, H727, UMC-11, and QGP-1 were infected with the suicide gene-armed measles vaccine virus MeV-SCD at indicated MOIs, which were adjusted to the respective tumor cell line-dependent sensitivity. At 3 hpi, the prodrug 5-FC was added. Tumor cells and supernatants were harvested at 3, 24, 48, 72, and 96 hpi, and viral titers were determined by TCID<sub>50</sub> titration. Displayed are mean and standard deviation of two independent experiments performed in duplicate.</p>
Full article ">Figure 9
<p>Susceptibility of human NET/NEC cells to mTOR-inhibitor everolimus. The NET/NEC tumor cell lines BON1, HROC57, H727, UMC-11, and QGP-1 were treated with increasing concentrations of everolimus, and tumor cell masses were measured at 96 h post-treatment (hpt) by SRB viability assay. Displayed are mean and standard deviation of two independent experiments performed in triplicate. MOCK: untreated control. ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 10
<p>Replication of MeV-SCD in five human NET/NEC cell lines with and without addition of everolimus. The NET/NEC tumor cell lines BON1, HROC57, H727, UMC-11, and QGP-1 were infected with the suicide gene-armed measles vaccine virus MeV-SCD at indicated MOIs, which were adjusted to the respective tumor cell-line-dependent sensitivity. At 3 hpi, the mTOR-inhibitor everolimus was also added in concentrations adjusted to the respective cell line-dependent sensitivity (for all cell lines, 1 nM with the exception of UMC-11, where 0.25 nM was used). Tumor cells and supernatants were harvested at 3, 24, 48, 72, and 96 hpi, and viral titers were determined by TCID<sub>50</sub> titration. Displayed are mean and standard deviation of two independent experiments performed in duplicate.</p>
Full article ">
16 pages, 3811 KiB  
Article
Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma
by Can Yurttas, Julia Beil, Susanne Berchtold, Irina Smirnow, Linus D. Kloker, Bence Sipos, Markus W. Löffler, Alfred Königsrainer, André L. Mihaljevic, Ulrich M. Lauer and Karolin Thiel
Cancers 2024, 16(2), 368; https://doi.org/10.3390/cancers16020368 - 15 Jan 2024
Viewed by 1715
Abstract
Effective treatment options for peritoneal surface malignancies (PSMs) are scarce. Oncolytic virotherapy with recombinant vaccinia viruses might constitute a novel treatment option for PSM. We aimed to identify the most effective oncolytic vaccinia virus strain in two murine mesothelioma cell lines and the [...] Read more.
Effective treatment options for peritoneal surface malignancies (PSMs) are scarce. Oncolytic virotherapy with recombinant vaccinia viruses might constitute a novel treatment option for PSM. We aimed to identify the most effective oncolytic vaccinia virus strain in two murine mesothelioma cell lines and the oncolytic potential in a murine model of peritoneal mesothelioma. Cell lines AB12 and AC29 were infected in vitro with vaccinia virus strains Lister (GLV-1h254), Western Reserve (GLV-0b347), and Copenhagen (GLV-4h463). The virus strain GLV-0b347 was shown most effective in vitro and was further investigated by intraperitoneal (i.p.) application to AB12 and AC29 mesothelioma-bearing mice. Feasibility, safety, and effectiveness of virotherapy were assessed by evaluating the peritoneal cancer index (PCI), virus detection in tumor tissues and ascites, virus growth curves, and comparison of overall survival. After i.p. injection of GLV-0b347, virus was detected in both tumor cells and ascites. In comparison to mock-treated mice, overall survival was significantly prolonged, ascites was less frequent and PCI values declined. However, effective treatment was only observed in animals with limited tumor burden at the time point of virus application. Nonetheless, intraperitoneal virotherapy with GLV-0b347 might constitute a novel therapeutic option for the treatment of peritoneal mesothelioma. Additional treatment modifications and combinational regimes will be investigated to further enhance treatment efficacy. Full article
(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
Show Figures

Figure 1

Figure 1
<p>Different strains of oncolytic vaccinia virus; (<b>top</b>): GLV-1h254 (Lister), (<b>middle</b>): GLV-4h463 (Copenhagen), and (<b>bottom</b>): GLV-0b347 (Western Reserve).</p>
Full article ">Figure 2
<p>Schematic illustration of the timing of treatment procedures in the in vivo experiments. Infection of tumors by intraperitoneal virus application was assessed by experiments that were terminated 24 h and 48 h post infection, respectively. Overall survival was investigated over 14 days after intraperitoneal virus application.</p>
Full article ">Figure 3
<p>Viability of murine peritoneal mesothelioma cell lines after treatment with different vaccinia virus strains. AB12 (<b>A</b>) and AC29 (<b>B</b>) tumor cells were infected with GLV-0b347 (Western Reserve), GLV-1h254 (Lister) or GLV-4h463 (Copenhagen) at various multiplicities of infection (MOIs) ranging from 0.0001 to 1 or remained uninfected (mock). At 96 h post infection (hpi), the remaining tumor cell masses were determined by SRB viability assay. Vaccinia virus mediated oncolysis was calculated relative to mock control. The mean ± SD of at least two independent experiments performed in quadruplicates is shown. For clarity reasons, only the lowest MOI that first reached statistical significance is annotated by asterisks. <span class="html-italic">p</span> ≤ 0.01 (**), <span class="html-italic">p</span> ≤ 0.0001 (****).</p>
Full article ">Figure 4
<p>Viral replication of different vaccinia virus strains in murine peritoneal mesothelioma cell lines. AB12 (<b>A</b>) and AC29 (<b>B</b>) tumor cells were infected with GLV-0b347 (Western Reserve), GLV-1h254 (Lister) or GLV-4h463 (Copenhagen) at indicated MOIs and viral replication was analyzed via plaque assay at 1, 24, 48, 72, and 96 hpi. The mean ± SD of at least two independent experiments performed in duplicates is shown. hpi: hours post infection; MOI: multiplicity of infection; pfu: plaque-forming units.</p>
Full article ">Figure 5
<p>Intraperitoneal treatment of peritoneal mesothelioma in a murine tumor model of AC29 tumor cells in CBA/j mice with GLV-0b347. (<b>A</b>) Open implantation of AC29 cells into the peritoneal cavity of anesthetized CBA/j mouse. (<b>B</b>) Two-layered abdominal wall closure with braided sutures. (<b>C</b>) Exploration of the abdominal cavity after euthanasia 48 h after intraabdominal virus application showing multiple indured tumor formations. The tweezers point to a subphrenic mass of peritoneal mesothelioma beneath the left diaphragm.</p>
Full article ">Figure 6
<p>Detection of infectious GLV-0b347 viral particles (pfu/mL) in tumor lysates 24 and 48 h after treatment of i.p. tumors in AB12 tumor cell-bearing BALB/c mice (<span class="html-italic">n</span> = 5) (<b>A</b>) and AC29 tumor cells in CBA/j mice (<span class="html-italic">n</span> = 5) (<b>B</b>), respectively, and extent of peritoneal tumors quantified by PCI value according to Ottow et al. [<a href="#B28-cancers-16-00368" class="html-bibr">28</a>]. hpi: hours post infection; i.p.: intraperitoneal; pfu: plaque-forming unit; PCI: peritoneal-cancer index.</p>
Full article ">Figure 7
<p>Survival of AB12 tumor-bearing BALB/c mice (<span class="html-italic">n</span> = 10) (<b>A</b>) and AC29 tumor-bearing CBA/j mice (<span class="html-italic">n</span> = 10) (<b>B</b>) in the course of 14 days after virus treatment with GLV-0b347 (green) and in control (mock; black), respectively. There was no statistically significant (ns) difference regarding survival between treatment groups. dpi: days post infection; ns: not significant.</p>
Full article ">Figure 8
<p>Kaplan–Meier survival curves of AB12 (<span class="html-italic">n</span> = 10) (<b>A</b>) or AC29 (<span class="html-italic">n</span> = 10) (<b>B</b>) tumor-bearing mice treated with modified experimental conditions including surgical implantation of a reduced tumor cell number and earlier onset of i.p. virotherapy with GLV-0b347 (green) compared to control animals (mock; black) until 14 dpi. dpi: days post infection. <span class="html-italic">p</span> &lt; 0.01 (**), <span class="html-italic">p</span> &lt; 0.001 (***).</p>
Full article ">Figure 9
<p>Intra-abdominal tumor burden given as peritoneal cancer index (PCI) quantified according to Ottow et al. [<a href="#B28-cancers-16-00368" class="html-bibr">28</a>] at individual end of experiment based on either signs of strain or maximum 14 days after virus application in AB12 (<span class="html-italic">n</span> = 10) (<b>A</b>) or AC29 (<span class="html-italic">n</span> = 10) (<b>B</b>) tumor-bearing mice treated with GLV-0b347 i.p. compared to control animals (mock). (<b>C</b>) Presence of ascites in AC29 mice (<span class="html-italic">n</span> = 10) treated with GLV-0b347 compared to control animals (mock). Each symbol indicates one mouse. The strength of agreement is given by the number of crosses: (<sup>x</sup>) indicates poor (≤0.2) agreement, (<sup>xx</sup>) fair (&gt;0.2–0.4) agreement.</p>
Full article ">Figure 10
<p>AB12 tumor cells in BALB/c mice after mock treatment show tumor deposits (indicated by white arrows) at the parietal and visceral peritoneum (<b>A</b>) compared to GLV-0b347-treated animals with hardly any tumor left over (<b>B</b>) at the time of necropsy. (<b>C</b>,<b>D</b>) Depict AC29 cells in CBA/j mock-treated mice with excessive tumor load ((<b>C</b>), white arrows) compared to virus-treated mice without any signs of residual tumors (<b>D</b>).</p>
Full article ">
23 pages, 10094 KiB  
Article
Distributed Cooperative Tracking Control Strategy for Virtual Coupling Trains: An Event-Triggered Model Predictive Control Approach
by Zhongqi Li, Lingyu Zhong, Hui Yang and Liang Zhou
Processes 2023, 11(12), 3293; https://doi.org/10.3390/pr11123293 - 24 Nov 2023
Cited by 2 | Viewed by 1013
Abstract
Virtual coupling (VC) technology has received much attention because of its significant advantages in enhancing the railway transport capacity; it achieves efficient train coupling operation through advanced communication technology. However, due to the uncertainty of the operating environment, a stable and effective control [...] Read more.
Virtual coupling (VC) technology has received much attention because of its significant advantages in enhancing the railway transport capacity; it achieves efficient train coupling operation through advanced communication technology. However, due to the uncertainty of the operating environment, a stable and effective control system is the key enabler for realization. In this paper, an event-triggered distributed model predictive control (ET-DMPC) method is proposed for the cooperative tracking control of virtual coupling trains (VCTS), considering resource limitations and multiple constraints. Firstly, a distributed model predictive control (DMPC) framework is designed. Based on the established VCTS dynamics model of the dual-leader communication topology, a distributed optimization objective function and safety constraints containing state information of the neighboring train system are constructed. Secondly, due to the limitations of communication and computational resources, the event triggering (ET) mechanism is further introduced, and an ET-DMPC method suitable for VCTS is proposed. The trigger condition of each unit train is designed on the premise of guaranteeing system stability, under which the system can guarantee the input-state stability (ISS), and the recursive feasibility of the system is proven via theoretical analysis. Finally, the VCTS composed of four CRH380A unit trains is used as the control object for simulation experiments, and through two sets of experimental simulation analysis, the effectiveness of the proposed method is verified. Full article
(This article belongs to the Special Issue Design and Control of Complex and Intelligent Systems)
Show Figures

Figure 1

Figure 1
<p>Illustration of VCTS operation mechanism based on RDBM.</p>
Full article ">Figure 2
<p>Topology diagram of virtual marshalling train.</p>
Full article ">Figure 3
<p>Block diagram of event-triggered distributed predictive control architecture.</p>
Full article ">Figure 4
<p>ET-DMPC algorithm flowchart.</p>
Full article ">Figure 5
<p>Leader train tracking reference curve.</p>
Full article ">Figure 6
<p>Velocity tracking error curve under two control methods.</p>
Full article ">Figure 7
<p>Distance tracking error curve under two control methods.</p>
Full article ">Figure 8
<p>Control output curve under two control methods.</p>
Full article ">Figure 9
<p>Trigger schedule.</p>
Full article ">Figure 10
<p>Velocity tracking error curves with different trigger parameters.</p>
Full article ">Figure 11
<p>Distance tracking error curves with different trigger parameters.</p>
Full article ">Figure 11 Cont.
<p>Distance tracking error curves with different trigger parameters.</p>
Full article ">Figure 12
<p>Control output curves with different trigger parameters.</p>
Full article ">
16 pages, 5525 KiB  
Article
Mapping Forest Abrupt Disturbance Events in Southeastern China—Comparisons and Tradeoffs of Landsat Time Series Analysis Algorithms
by Ning Ding and Mingshi Li
Remote Sens. 2023, 15(22), 5408; https://doi.org/10.3390/rs15225408 - 18 Nov 2023
Cited by 3 | Viewed by 1622
Abstract
Forest change monitoring is a fundamental and routine task for forest survey and planning departments, and the resulting forest change information acts as an underlying asset for sustainable forest management strategy development, ecological quality assessment, and carbon cycle research. The traditional ground-based manual [...] Read more.
Forest change monitoring is a fundamental and routine task for forest survey and planning departments, and the resulting forest change information acts as an underlying asset for sustainable forest management strategy development, ecological quality assessment, and carbon cycle research. The traditional ground-based manual monitoring of forest change has the disadvantages of high time and labor costs, low accessibility, and poor timeliness over wide regions. Remote sensing technology has become a popular approach for multi-scale forest change monitoring due to its multiple available spatial, spectral, temporal, and radiometric resolutions and wide coverage. Particularly, the free access policy of long time series archive data of Landsat (around 50 years) has triggered many automated analysis algorithms for landscape-scale forest change analysis, such as VCT, LandTrendr, BFAST, and CCDC. These automated algorithms differ in their principles, parameter settings, execution complexity, and disturbance types to be detected. Thus, selecting a suitable algorithm to satisfy the particular forest management demands is an urgent and challenging task for forest managers in a given forested area. In this study, Lishui City, Zhejiang Province, a typical plantation forest region in Southern China where forest disturbance widely and frequently exists, was selected as the study area. Based on the GEE platform, the algorithmic adaptability of VCT, LandTrendr, and CCDC in monitoring abrupt forest disturbance events was compared and assessed. The results showed that the kappa coefficients of the abrupt disturbance events detected by the three algorithms were at 0.704 (LandTrendr), 0.660 (VCT), and 0.727 (CCDC), and the corresponding overall accuracies were at 0.852, 0.830, and 0.862, respectively. The validated disturbance occurrence time consistency reached nearly 80% for the three algorithms. In light of the characteristics of forest disturbance occurrence in southeastern China as well as the algorithmic complexity, efficiency, and adaptability, LandTrendr was recommended as the most suitable one in this region or other similar regions. Overall, the forest change monitoring process based on GEE is becoming more simplified and easily implemented, and the comparisons and tradeoffs in this study provide a reference for the choice of long time series forest monitoring algorithms. Full article
(This article belongs to the Section Forest Remote Sensing)
Show Figures

Figure 1

Figure 1
<p>Maps showing the location of the study area and land cover types in 2000 at Lishui City, Zhejiang Province, China. The right map is the 2000 Land cover data supporting VCT algorithm running, which is a subset of the GlobeLAND30.</p>
Full article ">Figure 2
<p>The conceptual diagram of LandTrendr change detection algorithm [<a href="#B12-remotesensing-15-05408" class="html-bibr">12</a>]. After removal of ephemeral spikes (<b>a</b>), potential vertices are identified using deviation from simple regression lines (<b>b</b>) as much as possible. Then, excess vertices are removed based on low angle change (<b>c</b>), according to the max_segments, a single path of model was chosen (<b>d</b>) and creating successively simplified models of the trajectory with removing segments (<b>e</b>). The model with the best fit is chosen (<b>f</b>).</p>
Full article ">Figure 3
<p>Schematic diagram of CCDC fitting model [<a href="#B34-remotesensing-15-05408" class="html-bibr">34</a>]. (<b>A</b>) shows the results of a simple model fitting, (<b>B</b>) shows an advanced model fitting, and (<b>C</b>) shows the full model fitting to derive three sets of coefficients.</p>
Full article ">Figure 4
<p>The validated temporal accuracy dynamics of LandTrendr, VCT, and CCDC detected abrupt forest change events.</p>
Full article ">Figure 5
<p>Forest abrupt changes mapping from 1990 to 2020 in Lishui derived from LandTrendr (<b>A</b>), VCT (<b>B</b>), and CCDC (<b>C</b>) algorithms.</p>
Full article ">Figure 6
<p>The validation of the progressive abrupt disturbance events detected by VCT, LandTrendr, and CCDC by using high spatial resolution Google Earth Maps and Landsat images. Locations labeled as a and b show the difference between the responses of Landtrendr and CCDC to the time of change.</p>
Full article ">
11 pages, 1014 KiB  
Article
Injury of the Vestibulocerebellar Tract and Signs of Ataxia in Patients with Cerebellar Stroke
by Sang-Seok Yeo, Seung-Min Nam and In-Hee Cho
J. Clin. Med. 2023, 12(21), 6877; https://doi.org/10.3390/jcm12216877 - 31 Oct 2023
Viewed by 1425
Abstract
Background: The vestibulocerebellar tract (VCT) is responsible for maintaining balance, spatial orientation, and coordination. Damage to the vestibular system is accompanied by symptoms of balance disorder or ataxia. This study aimed to compare cerebellar dysfunction according to VCT damage in patients with cerebellar [...] Read more.
Background: The vestibulocerebellar tract (VCT) is responsible for maintaining balance, spatial orientation, and coordination. Damage to the vestibular system is accompanied by symptoms of balance disorder or ataxia. This study aimed to compare cerebellar dysfunction according to VCT damage in patients with cerebellar stroke. Methods: Six patients with cerebellum injury were recruited. This study measured ataxia and hand function related to visuomotor integration and manual dexterity using the Purdue pegboard test. The primary and bilateral secondary VCTs were reconstructed to investigate the integrity of pathways using diffusion tensor imaging (DTI). Results: The ataxia sign was positive in five patients (83%) at onset. In the result of the pegboard test, all patients had hand dysfunction in the dominant hand (100%). Likewise, all patients also had non-dominant hand dysfunction (100%). On the DTI tractography, the left and right primary VCTs of the patients demonstrated a 25% injury rate. Furthermore, the injury rates of ipsilateral and contralateral secondary VCTs were 50% and 58%. Conclusions: Ataxia is related to secondary VCTs, and hand dysfunction is also related to VCTs. Therefore, we believe that the current study will be helpful in evaluating and providing a clinical intervention strategy for patients with ataxia and hand dysfunction following cerebellar injury. Full article
(This article belongs to the Section Clinical Rehabilitation)
Show Figures

Figure 1

Figure 1
<p>The vestibulocelebellar tract (VCT) is shown in a normal healthy adult and six patients according to diffusion tensor imaging (DTI) tractography. The right (red) and left VCTs (blue) are shown in the transverse plane, and the integrity of six patients suffering from spontaneous-intracerebral hemorrhage or infarction of the cerebellum is shown using DTI tractography. Among the primary and bilateral VCTs of each patient, the tract that was not completely reconstructed was marked as “none”.</p>
Full article ">
16 pages, 5696 KiB  
Article
The Applications and Pitfalls of Cone-Beam Computed Tomography-Based Synthetic Computed Tomography for Adaptive Evaluation in Pencil-Beam Scanning Proton Therapy
by Pingfang Tsai, Yu-Lun Tseng, Brian Shen, Christopher Ackerman, Huifang A. Zhai, Francis Yu, Charles B. Simone, J. Isabelle Choi, Nancy Y. Lee, Rafi Kabarriti, Stanislav Lazarev, Casey L. Johnson, Jiayi Liu, Chin-Cheng Chen and Haibo Lin
Cancers 2023, 15(20), 5101; https://doi.org/10.3390/cancers15205101 - 22 Oct 2023
Cited by 1 | Viewed by 1329
Abstract
Purpose: The study evaluates the efficacy of cone-beam computed tomography (CBCT)-based synthetic CTs (sCT) as a potential alternative to verification CT (vCT) for enhanced treatment monitoring and early adaptation in proton therapy. Methods: Seven common treatment sites were studied. Two sets of sCT [...] Read more.
Purpose: The study evaluates the efficacy of cone-beam computed tomography (CBCT)-based synthetic CTs (sCT) as a potential alternative to verification CT (vCT) for enhanced treatment monitoring and early adaptation in proton therapy. Methods: Seven common treatment sites were studied. Two sets of sCT per case were generated: direct-deformed (DD) sCT and image-correction (IC) sCT. The image qualities and dosimetric impact of the sCT were compared to the same-day vCT. Results: The sCT agreed with vCT in regions of homogeneous tissues such as the brain and breast; however, notable discrepancies were observed in the thorax and abdomen. The sCT outliers existed for DD sCT when there was an anatomy change and for IC sCT in low-density regions. The target coverage exhibited less than a 5% variance in most DD and IC sCT cases when compared to vCT. The Dmax of serial organ-at-risk (OAR) in sCT plans shows greater deviation from vCT than small-volume dose metrics (D0.1cc). The parallel OAR volumetric and mean doses remained consistent, with average deviations below 1.5%. Conclusion: The use of sCT enables precise treatment and prompt early adaptation for proton therapy. The quality assurance of sCT is mandatory in the early stage of clinical implementation. Full article
(This article belongs to the Collection Particle Therapy: State-of-the-Art and Future Prospects)
Show Figures

Figure 1

Figure 1
<p>Dose difference between synthetic CT and reference verification CT on the same day for H&amp;N treatment site.</p>
Full article ">Figure 2
<p>Dose difference between synthetic CT and reference verification CT on the same day for brain treatment site.</p>
Full article ">Figure 3
<p>Dose difference between synthetic CT and reference verification CT on the same day for lung treatment site.</p>
Full article ">Figure 4
<p>Dose difference between synthetic CT and reference verification CT on the same day for breast treatment site.</p>
Full article ">Figure 5
<p>Dose difference between synthetic CT and reference verification CT on the same day for pelvis treatment site.</p>
Full article ">Figure 6
<p>Dose difference between synthetic CT and reference verification CT on the same day for prostate with pelvic lymph node treatment site.</p>
Full article ">Figure 7
<p>Dose difference between synthetic CT and reference verification CT on the same day for abdomen treatment site.</p>
Full article ">Figure 8
<p>Depictions of discrepancies in synthetic CT images. (<b>A</b>) Case 1—An aliasing effect was observed near the posterior part of the brain where the CBCT FOV edge integrates with the planning CT. (<b>B</b>) Case 2—An aliasing effect was observed in the superior–inferior direction at the merged boundary, leading to an isocenter displacement error (isocenter in yellow circle) (for comparison, the original planning isocenter location is displayed in the bottom left). (<b>C</b>) Case 3—A distorted support couch structure in the DD sCT.</p>
Full article ">Figure 9
<p>Differences in Hounsfield unit (HU) values between the image-corrected (IC) synthetic CT and the reference verification CT. The color bar indicates an HU discrepancy scale, spanning from 100 to 1000 HU. (<b>A</b>) Immobilization head cushion area; (<b>B</b>) nasal sinus region; (<b>C</b>) lung tissue and Vac-Lok <sup>TM</sup> region.</p>
Full article ">Figure 10
<p>Disparities between the direct-deformable (DD) synthetic CT and the CBCT taken on the same day. Scenarios highlighted are: (<b>A</b>) tumor shrinkage within the cavity; (<b>B</b>) chest wall expansion; (<b>C</b>) discrepancies in bowel content; (<b>D</b>) hip prosthesis artifact. The color bar represents an HU difference scale from 100 to 1000 HU.</p>
Full article ">
22 pages, 14348 KiB  
Article
Study on the Effect of Structural Parameters of Volume Control Tank on Gas–Liquid Mass Transfer
by Jian Hu, Weiguang Li, Xiangyu Chi and Naihua Wang
Energies 2023, 16(13), 4991; https://doi.org/10.3390/en16134991 - 27 Jun 2023
Cited by 1 | Viewed by 1047
Abstract
The volume control tank (VCT) is an important facility in the primary circuit of nuclear power plants. During the normal operation of nuclear power plants, the mass transfer between the gas and liquid phases occurs in the VCT at all times. It is [...] Read more.
The volume control tank (VCT) is an important facility in the primary circuit of nuclear power plants. During the normal operation of nuclear power plants, the mass transfer between the gas and liquid phases occurs in the VCT at all times. It is driven by submerged jets, which may cause potential risks to the operational safety of nuclear power plants. It is necessary to conduct an in-depth study to gain a deeper understanding of the gas–liquid mass transfer behavior in the VCT. In this paper, a new gas–liquid mass transfer model is developed that combines a surface divergence model with a CFD model to accurately simulate the mass transfer process of the gas phase into the liquid phase. The simulation data were verified by the experimental results. The deviation between the simulation results and experimental results is less than 6.55%. Based on this model, a simulation study was carried out for the effect of structural parameters of the VCT on gas–liquid mass transfer. The results show that the double-vortex structure above the jet inlet, the surface jet at the gas–liquid interface, and the vortex at the end of the jet are the three factors dominating the gas–liquid mass transfer in the VCT. The gas–liquid mass transfer can be influenced by the jet diameter since the jet diameter has a remarkable effect on the Kolmogorov scale and the macroscopic flow field structure. Moreover, both the Kolmogorov scale and the macroscopic flow field structure can be affected by the jet height. However, these two effects cancel each other out. Thus, the influence of the jet height on the gas–liquid mass transfer rate is negligible. Full article
Show Figures

Figure 1

Figure 1
<p>RCV system diagram.</p>
Full article ">Figure 2
<p>Geometric model.</p>
Full article ">Figure 3
<p>CFD mesh.</p>
Full article ">Figure 4
<p>Experimental system diagram.</p>
Full article ">Figure 5
<p>Physical diagram of the VCT.</p>
Full article ">Figure 6
<p>Structure of the VCT (mm).</p>
Full article ">Figure 7
<p>Jet inlet (mm): (<b>a</b>) Inner diameter is 16 mm; (<b>b</b>) Inner diameter is 32 mm; (<b>c</b>) Inner diameter is 49 mm.</p>
Full article ">Figure 8
<p>Concentration field distribution of the VCT: (<b>a</b>) Symmetry; (<b>b</b>) Wall. (t = 1500 s).</p>
Full article ">Figure 9
<p>Outlet concentration and volume-averaged concentration curves of oxygen in the VCT.</p>
Full article ">Figure 10
<p>Streamline chart of the VCT: (<b>a</b>) Streamline chart of the gas–liquid interface; (<b>b</b>) Streamline chart of the symmetry plane. (t = 1500 s).</p>
Full article ">Figure 11
<p>Experimental correlation equation for the dimensionless mass transfer coefficient (<span class="html-italic">Sh</span>).</p>
Full article ">Figure 12
<p>Dissolved oxygen concentration curves at the outlet of the VCT for different jet diameters: (<b>a</b>) Q1; (<b>b</b>) Q2.</p>
Full article ">Figure 13
<p>Dissolved oxygen concentration curves at the outlet of the VCT at different jet heights.</p>
Full article ">Figure 14
<p>Comparison of CFD data with EXP data.</p>
Full article ">Figure 15
<p>Kolmogorov scale distribution at the gas–liquid interface: (<b>a</b>) CFD-H1D2Q1; (<b>b</b>) CFD-H1D1Q1. (t = 1500 s).</p>
Full article ">Figure 16
<p>Effect of jet diameter on Kolmogorov scale.</p>
Full article ">Figure 17
<p>Effect of jet diameter on velocity.</p>
Full article ">Figure 18
<p>Turbulent viscosity distribution at the gas–liquid interface: (<b>a</b>) CFD-H1D2Q1; (<b>b</b>) CFD-H1D1Q1. (t = 1500 s).</p>
Full article ">Figure 19
<p>Effect of jet height on the streamline chart: (<b>a</b>) CFD-H1D2Q1; (<b>b</b>) CFD-H2D2Q1. (t = 1500 s; the left side is the legend of the symmetry plane, and the upper side is the legend of the division interface).</p>
Full article ">Figure 20
<p>Effect of jet height on velocity.</p>
Full article ">Figure 21
<p>Turbulent viscosity distribution at the gas–liquid interface: (<b>a</b>) CFD-H1D2Q1; (<b>b</b>) CFD-H2D2Q1. (t = 1500 s).</p>
Full article ">Figure 22
<p>Kolmogorov scale distribution at the gas–liquid interface: (<b>a</b>) CFD-H1D2Q1; (<b>b</b>) CFD-H2D2Q1. (t=1500 s).</p>
Full article ">Figure 23
<p>Effect of jet height on Kolmogorov scale.</p>
Full article ">
16 pages, 4186 KiB  
Article
Deep Learning-Based Symptomizing Cyber Threats Using Adaptive 5G Shared Slice Security Approaches
by Abdul Majeed, Abdullah M. Alnajim, Athar Waseem, Aleem Khaliq, Aqdas Naveed, Shabana Habib, Muhammad Islam and Sheroz Khan
Future Internet 2023, 15(6), 193; https://doi.org/10.3390/fi15060193 - 26 May 2023
Cited by 7 | Viewed by 1993
Abstract
In fifth Generation (5G) networks, protection from internal attacks, external breaches, violation of confidentiality, and misuse of network vulnerabilities is a challenging task. Various approaches, especially deep-learning (DL) prototypes, have been adopted in order to counter such challenges. For 5G network defense, DL [...] Read more.
In fifth Generation (5G) networks, protection from internal attacks, external breaches, violation of confidentiality, and misuse of network vulnerabilities is a challenging task. Various approaches, especially deep-learning (DL) prototypes, have been adopted in order to counter such challenges. For 5G network defense, DL module are recommended here in order to symptomize suspicious NetFlow data. This module behaves as a virtual network function (VNF) and is placed along a 5G network. The DL module as a cyber threat-symptomizing (CTS) unit acts as a virtual security scanner along the 5G network data analytic function (NWDAF) to monitor the network data. When the data were found to be suspicious, causing network bottlenecks and let-downs of end-user services, they were labeled as “Anomalous”. For the best proactive and adaptive cyber defense system (PACDS), a logically organized modular approach has been followed to design the DL security module. In the application context, improvements have been made to input features dimension and computational complexity reduction with better response times and accuracy in outlier detection. Moreover, key performance indicators (KPIs) have been proposed for security module placement to secure interslice and intraslice communication channels from any internal or external attacks, also suggesting an adaptive defense mechanism and indicating its placement on a 5G network. Among the chosen DL models, the CNN model behaves as a stable model during behavior analysis in the results. The model classifies botnet-labeled data with 99.74% accuracy and higher precision. Full article
(This article belongs to the Special Issue 5G Security: Challenges, Opportunities, and the Road Ahead)
Show Figures

Figure 1

Figure 1
<p>Adaptive defense systems—ADS [<a href="#B17-futureinternet-15-00193" class="html-bibr">17</a>].</p>
Full article ">Figure 2
<p>Proactive and adaptive cyber defense system design flow-graph.</p>
Full article ">Figure 3
<p>Synthetic minority oversampling technique—SMOTE [<a href="#B22-futureinternet-15-00193" class="html-bibr">22</a>].</p>
Full article ">Figure 4
<p>CTS module analysis flow-chart.</p>
Full article ">Figure 5
<p>Multi-tier placement of vCTS modules on security PoPs.</p>
Full article ">Figure 6
<p>High-level MANO plane using NFV architecture [<a href="#B29-futureinternet-15-00193" class="html-bibr">29</a>,<a href="#B30-futureinternet-15-00193" class="html-bibr">30</a>].</p>
Full article ">Figure 7
<p>Symptoms detection system—two-tier approach [<a href="#B29-futureinternet-15-00193" class="html-bibr">29</a>].</p>
Full article ">Figure 8
<p>Bi-LSTM train–test loss vs. accuracy.</p>
Full article ">Figure 9
<p>Confusion matrix—Bi-LSTM.</p>
Full article ">Figure 10
<p>CNN-LSTM train–test loss vs. accuracy.</p>
Full article ">Figure 11
<p>Confusion matrix CNN-LSTM.</p>
Full article ">Figure 12
<p>CNN train–test loss vs. accuracy.</p>
Full article ">Figure 13
<p>Confusion matrix—CNN.</p>
Full article ">
21 pages, 4773 KiB  
Article
Receiving Routing Approach for Virtually Coupled Train Sets at a Railway Station
by Yinggui Zhang, Qianying Xu, Runchuan Yu, Minghui Zhao and Jiachen Liu
Mathematics 2023, 11(9), 2002; https://doi.org/10.3390/math11092002 - 23 Apr 2023
Viewed by 1214
Abstract
Elaborated in several forms before being formally defined, virtually coupled train sets (VCTS) have become an issue for capacity increase with obvious shorter train intervals. As the station organization strategy is still ambiguous due to the lack of literature, the receiving routing problem [...] Read more.
Elaborated in several forms before being formally defined, virtually coupled train sets (VCTS) have become an issue for capacity increase with obvious shorter train intervals. As the station organization strategy is still ambiguous due to the lack of literature, the receiving routing problem for VCTS is studied in particular. First, the existing concept of VCTS is explained, which refers to the virtual connection of trains through safe and reliable communication technology, allowing short-interval collaborative operations without the need for physical equipment. Subsequently, the operating characteristics and receiving requirements are analyzed. With a summary of factors affecting receiving operations, a mathematical model is proposed with the objectives of minimizing operation duration and maximizing effectiveness, which is solved by an improved genetic algorithm (GA) with an elitist and adaptive strategy. Numerical tests are carried out 250 times based on a practical station and EMU parameters. The macro results show the valid pursuit of designed objectives with an average duration of 204.95 s and an efficiency of 91.76%. Microevolution of an optimal scheme indicates that safety requirements are met while the process duration is only 35.83% of the original CTCS-3 mode. Full article
Show Figures

Figure 1

Figure 1
<p>A schematic example of interval calculation is proposed based on two adjacent trains running under VCTS.</p>
Full article ">Figure 2
<p>The distance–speed curves of different levels for trains braking from 200 km/h reflect multiple characteristics of their process.</p>
Full article ">Figure 3
<p>The form of the real-coded chromosome is an intuitive reflection of its practical meaning.</p>
Full article ">Figure 4
<p>The individual genotype is valued by train tasks to ensure its superiority and diversity in the process of population initialization.</p>
Full article ">Figure 5
<p>Nodes are reset to suit the applications for VCTS and their distances are given as black numbers.</p>
Full article ">Figure 6
<p>More profitable schemes were repeated more often, while the others have less frequent occurrences.</p>
Full article ">Figure 7
<p>The histogram and summation curve report the situation of right inclination.</p>
Full article ">Figure 8
<p>The selection results mainly focus on the first four durations with short operation time, as the last one is well out of the former range.</p>
Full article ">Figure 9
<p>Scheme concentration occurs in the bottom-right area, which means the approaches here are operating fast and efficiently.</p>
Full article ">Figure 10
<p>Changing curve of fitness reflects the optimistic effect of the optimization model to a certain extent.</p>
Full article ">Figure 11
<p>The connection usage of each node can be used to calculate the spacing relation for trains and determine whether the use of the turnout conforms to the set security requirements under VCTS.</p>
Full article ">Figure 12
<p>The connection usage of nodes under the operation environment of CTCS-3 is much sparser than VCTS.</p>
Full article ">
Back to TopTop